Lugano, Switzerland, 23 February 2021 - The ESMO Targeted Anticancer Therapies Congress 2021, designed for basic scientists, physicians and translational researchers belonging to academic settings, industry and regulatory agencies will be held as a virtual meeting. (1)
The scientific programme will provide new data and insightful presentations in the area of drug discovery and development for a broad range of targets, precision medicine and early clinical trial methodology. (2) World renowned experts will discuss breakthroughs in the microbiome, oncolytic viruses and how to incorporate genomics into early drug development.
Programme highlights
- Immune based therapies including ADCs, cytokines, multitargeted agents and cell-based therapies
- Oncolytic viruses
- The microbiome as a tool and a target
- Pre-clinical testing to identify effective combination strategies
- Incorporating genomics into early drug development
- Practical aspects of optimising molecular tumour boards for phase I trials
TAT2021 Honorary Award
Prof. Ruth Plummer will be presented with the TAT 2021 Honorary Award for taking many new cancer drugs into the clinic that have become standard treatments with proven patient benefit. She will deliver a keynote lecture entitled "Academic drug discovery - Is partnership with industry a marriage made in heaven?" (Monday 1 March, from 11:40 to 12:45). (3)
During the same session Dr. Lillian Siu, recipient of the TAT 2020 Honorary Award for her pivotal contributions in the development of new anticancer drugs, will also deliver her keynote lecture entitled "Rear view mirror and crystal ball of oncology drug development". (4)
###
Media registration
ESMO welcomes media interested in reporting from the ESMO events and on cancer issues. Only through the official accreditation process with the ESMO Media Registration Form, accredited media representatives will be able to access scientific and educational sessions (live streamed and on-demand), live chat and Q&A, e-posters, virtual exhibition and industry satellite symposia, Congress webcasts.? (5)
Further information
ESMO Press Office
media@esmo.org
-END-
Notes to Editors
Please make sure to use the official name of the meeting in your reports: ESMO Targeted Anticancer Therapies Virtual Congress 2021
Official Congress Hashtag: #ESMOTAT21
References
(1) ESMO Targeted Anticancer Therapies Congress 2021
https://www.esmo.org/meetings/esmo-targeted-anticancer-therapies-virtual-congress-2021
(2) Scientific programme
https://cslide.ctimeetingtech.com/tat2021/attendee/confcal/session/calendar
(3) TAT 2021 Honorary Award
https://www.esmo.org/newsroom/press-office/tat-2021-honorary-award-a-recognition-in-cancer-drug-development-to-ruth-plummer
(4) TAT 2020 Honorary Award
https://www.esmo.org/newsroom/press-office/cancer-drug-development-award-siu-tat
(5) Media Registration Form
https://esmo.formstack.com/forms/media_registration_form_tat_2021
About the European Society for Medical Oncology (ESMO)
ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. ESMO is committed to offer the best care to people with cancer, through fostering integrated cancer care, supporting oncologists in their professional development, and advocating for sustainable cancer care worldwide. Visit http://www.esmo.org
About ESMO Targeted Anticancer Therapies Congress
The TAT Congress is a well-differentiated ESMO event focusing on early phase drug development and translational research. The TAT Congress series has been at the forefront of revolutionary transformation in early drug development and has succeeded in broadening the conversation on phase I trials to include a wide circle of stakeholders.